Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lacuna Apo Biotech Fund is a Luxembourg-based investment fund (SICAV) that specializes in the global healthcare and biotechnology sectors. Historically managed by Lacuna GmbH and advised by Adamant Biomedical Investments AG, the fund focuses on identifying and investing in small- and mid-cap companies within the biotech, medtech, and specialty pharmaceutical industries. The fund has participated in significant financing rounds for various life science companies, including S*BIO, Auris Medical, and Orphan Medical. It employs a fundamental bottom-up investment strategy to select high-growth opportunities in the healthcare market. The fund was notable for being one of the early investment vehicles in the DACH region dedicated to the international life sciences space. While the specific 'Apo Biotech' vintage is no longer the primary focus of Lacuna's current offerings, it laid the groundwork for the firm's subsequent healthcare investment products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lacuna Apo Biotech Fund.